Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | TELA Bio, Inc. TELA | Nantahala Capital Management, LLC | 3,974,326 9.990% | 2,059,200 (+107.52%) | Filing History |
| 2025-02-13 12:07 pm Sale | 2024-12-31 | 13G | TELA Bio, Inc. TELA | Stonepine Capital Management, LLC | 2,353,099 6.000% | -478,740 (-16.91%) | Filing History |
| 2025-02-12 3:54 pm Purchase | 2024-12-31 | 13G | TELA Bio, Inc. TELA | SILVERARC CAPITAL MANAGEMENT LLC | 3,065,649 7.800% | 3,065,649 (New Position) | Filing History |
| 2025-01-31 4:05 pm Purchase | 2024-12-31 | 13G | TELA Bio, Inc. TELA | HIRSCHMAN ORIN | 2,662,785 6.800% | 1,284,840 (+93.24%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | TELA Bio, Inc. TELA | Nantahala Capital Management, LLC | 1,915,126 7.749% | 1,915,126 (New Position) | Filing History |
| 2024-11-14 1:06 pm Purchase | 2024-09-30 | 13G | TELA Bio, Inc. TELA | Laurence W. Lytton | 2,452,257 9.900% | 1,112,205 (+83.00%) | Filing History |
| 2024-10-29 5:12 pm Purchase | 2024-10-23 | 13G | TELA Bio, Inc. TELA | Stonepine Capital Management, LLC | 2,831,839 7.700% | 2,831,839 (New Position) | Filing History |
| 2024-10-28 4:06 pm Unchanged | 2024-10-24 | 13G | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 10.440% | 0 (Unchanged) | Filing History |
| 2024-10-25 4:24 pm Sale | 2024-10-23 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 1,182,717 4.800% | -941,550 (-44.32%) | Filing History |
| 2024-10-01 5:35 pm Sale | 2024-09-27 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,124,267 8.600% | -313,700 (-12.87%) | Filing History |
| 2024-07-30 5:50 pm Purchase | 2024-07-24 | 13G | TELA Bio, Inc. TELA | GROW FUNDS, LLC. | 1,402,017 5.700% | 1,402,017 (New Position) | Filing History |
| 2024-07-22 3:20 pm Purchase | 2024-07-10 | 13G | TELA Bio, Inc. TELA | Laurence W. Lytton | 1,340,052 5.400% | 1,340,052 (New Position) | Filing History |
| 2024-07-02 4:58 pm Sale | 2024-06-28 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,437,967 9.900% | -428,300 (-14.94%) | Filing History |
| 2024-06-10 09:00 am Sale | 2024-05-31 | 13G | TELA Bio, Inc. TELA | First Light Asset Management, LLC | 0 0.000% | -2,723,028 (Position Closed) | Filing History |
| 2024-02-14 5:23 pm Purchase | 2023-12-31 | 13G | TELA Bio, Inc. TELA | First Light Asset Management, LLC | 2,723,028 11.120% | 194,428 (+7.69%) | Filing History |
| 2024-02-14 06:35 am Purchase | 2023-12-31 | 13G | TELA Bio, Inc. TELA | EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 16.790% | 5,000 (+0.12%) | Filing History |
| 2024-02-07 6:55 pm Sale | 2023-12-31 | 13G | TELA Bio, Inc. TELA | HIRSCHMAN ORIN | 1,377,945 5.600% | -301,336 (-17.94%) | Filing History |
| 2023-10-06 11:47 am Purchase | 2023-09-30 | 13G | TELA Bio, Inc. TELA | First Light Asset Management, LLC | 2,528,600 10.330% | 2,528,600 (New Position) | Filing History |
| 2023-04-21 5:03 pm Sale | 2023-04-19 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,866,267 11.900% | -192,000 (-6.28%) | Filing History |
| 2023-02-15 06:56 am Purchase | 2022-12-31 | 13G | TELA Bio, Inc. TELA | HIRSCHMAN ORIN | 1,679,281 8.700% | 161,289 (+10.63%) | Filing History |